An Update on mRNA-Based Viral Vaccines

With the success of COVID-19 vaccines, newly created mRNA vaccines against other infectious diseases are beginning to emerge. Here, we review the structural elements required for designing mRNA vaccine constructs for effective in vitro synthetic transcription reactions. The unprecedently speedy deve...

Full description

Bibliographic Details
Main Authors: Subbiah Jeeva, Ki-Hye Kim, Chong Hyun Shin, Bao-Zhong Wang, Sang-Moo Kang
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/9/965
_version_ 1797517032915206144
author Subbiah Jeeva
Ki-Hye Kim
Chong Hyun Shin
Bao-Zhong Wang
Sang-Moo Kang
author_facet Subbiah Jeeva
Ki-Hye Kim
Chong Hyun Shin
Bao-Zhong Wang
Sang-Moo Kang
author_sort Subbiah Jeeva
collection DOAJ
description With the success of COVID-19 vaccines, newly created mRNA vaccines against other infectious diseases are beginning to emerge. Here, we review the structural elements required for designing mRNA vaccine constructs for effective in vitro synthetic transcription reactions. The unprecedently speedy development of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was enabled with previous innovations in nucleoside modifications during in vitro transcription and lipid nanoparticle delivery materials of mRNA. Recent updates are briefly described in the status of mRNA vaccines against SARS-CoV-2, influenza virus, and other viral pathogens. Unique features of mRNA vaccine platforms and future perspectives are discussed.
first_indexed 2024-03-10T07:09:51Z
format Article
id doaj.art-a32a5485ee6f4f3cae37db81ddb506cf
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T07:09:51Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-a32a5485ee6f4f3cae37db81ddb506cf2023-11-22T15:34:09ZengMDPI AGVaccines2076-393X2021-08-019996510.3390/vaccines9090965An Update on mRNA-Based Viral VaccinesSubbiah Jeeva0Ki-Hye Kim1Chong Hyun Shin2Bao-Zhong Wang3Sang-Moo Kang4Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USACenter for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USACenter for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USACenter for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USACenter for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USAWith the success of COVID-19 vaccines, newly created mRNA vaccines against other infectious diseases are beginning to emerge. Here, we review the structural elements required for designing mRNA vaccine constructs for effective in vitro synthetic transcription reactions. The unprecedently speedy development of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was enabled with previous innovations in nucleoside modifications during in vitro transcription and lipid nanoparticle delivery materials of mRNA. Recent updates are briefly described in the status of mRNA vaccines against SARS-CoV-2, influenza virus, and other viral pathogens. Unique features of mRNA vaccine platforms and future perspectives are discussed.https://www.mdpi.com/2076-393X/9/9/965mRNA vaccinesSARS-CoV-2influenza
spellingShingle Subbiah Jeeva
Ki-Hye Kim
Chong Hyun Shin
Bao-Zhong Wang
Sang-Moo Kang
An Update on mRNA-Based Viral Vaccines
Vaccines
mRNA vaccines
SARS-CoV-2
influenza
title An Update on mRNA-Based Viral Vaccines
title_full An Update on mRNA-Based Viral Vaccines
title_fullStr An Update on mRNA-Based Viral Vaccines
title_full_unstemmed An Update on mRNA-Based Viral Vaccines
title_short An Update on mRNA-Based Viral Vaccines
title_sort update on mrna based viral vaccines
topic mRNA vaccines
SARS-CoV-2
influenza
url https://www.mdpi.com/2076-393X/9/9/965
work_keys_str_mv AT subbiahjeeva anupdateonmrnabasedviralvaccines
AT kihyekim anupdateonmrnabasedviralvaccines
AT chonghyunshin anupdateonmrnabasedviralvaccines
AT baozhongwang anupdateonmrnabasedviralvaccines
AT sangmookang anupdateonmrnabasedviralvaccines
AT subbiahjeeva updateonmrnabasedviralvaccines
AT kihyekim updateonmrnabasedviralvaccines
AT chonghyunshin updateonmrnabasedviralvaccines
AT baozhongwang updateonmrnabasedviralvaccines
AT sangmookang updateonmrnabasedviralvaccines